Andrew S. Davis - 01 Oct 2021 Form 4 Insider Report for Silk Road Medical Inc

Role
Chief Commercial Officer
Signature
/s/Mhairi Jones, by power of attorney
Issuer symbol
N/A
Transactions as of
01 Oct 2021
Net transactions value
-$310,966
Form type
4
Filing time
05 Oct 2021, 20:24:57 UTC
Previous filing
03 Sep 2021
Next filing
02 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Options Exercise $17,846 +3,773 +5.4% $4.73 74,028 01 Oct 2021 Direct F1
transaction SILK Common Stock Sale $203,373 -3,773 -5.1% $53.90 70,255 01 Oct 2021 Direct F1, F2
transaction SILK Common Stock Options Exercise $12,066 +2,551 +3.6% $4.73 72,806 01 Oct 2021 Direct F1
transaction SILK Common Stock Sale $137,505 -2,551 -3.5% $53.90 70,255 01 Oct 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Options Exercise $0 -3,773 -5.6% $0.000000 63,196 01 Oct 2021 Common Stock 3,773 $4.73 Direct F1, F3
transaction SILK Option (right to buy) Options Exercise $0 -2,551 -8.5% $0.000000 27,405 01 Oct 2021 Common Stock 2,551 $4.73 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020.
F2 This transaction was executed in multiple trades at price ranging from $52.94 to $54.63. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 All of the shares subject to this option are fully vested and exercisable as of the date hereof.